Search

everythinglearnresearchcommunity

for

Search:↓

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

A new method was developed to create better skin models for healing and reconstruction.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

MSC-protein helps regenerate gum tissue and bone.

TCF/Lef1 activity is essential for proper skin cell development and renewal.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

AMFIBHA scaffold significantly healed large full-thickness burn wounds in rabbits and restored skin's mechanical properties.

Human foreskin fibroblast–conditioned medium improved hair growth in androgenetic alopecia patients.

FERONIA is crucial for plant growth, pollen tube reception, and sugar signaling.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

The model helps understand scar contraction and develop new treatments.

Researchers developed a method to label and study human hair follicle stem cells using a fluorescent protein.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The new nanofiber improves wound healing by releasing growth factors, reducing inflammation, and helping skin regeneration.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

The hydrogel helps heal diabetic wounds by combining antibacterial, antioxidant, and immune-boosting effects.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

Hair follicle stem cells may help treat acute pancreatitis by reducing inflammation and aiding regeneration.

PCL nanoscaffold-based liver spheroids are effective for drug screening and studying liver toxicity.

HFMs can help study hair growth and test potential hair growth drugs.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Alpha 6 + /MHCI - cells have stem cell traits and are similar to mouse hair follicle stem cells.

Researchers found a way to turn skin cells into cells that can grow new hair.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

FLRG and follistatin have different roles in wound healing.